National International Holding Company K.S.C.P. (KWSE:NIH)
Kuwait flag Kuwait · Delayed Price · Currency is KWD
0.1430
0.00 (0.00%)
At close: Nov 16, 2026

KWSE:NIH Income Statement

Millions KWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3.874.064.044.464.323.34
Other Revenue
-0.992.524.133.492.522.51
2.886.588.187.956.845.85
Revenue Growth
-69.09%-19.50%2.82%16.25%16.92%3620.84%
Cost of Revenue
2.682.932.943.393.392.39
Gross Profit
0.23.655.234.563.453.46
Selling, General & Admin
1.651.761.61.731.571.53
Other Operating Expenses
-0.020.030.030.030-0.07
Operating Expenses
1.671.831.631.751.581.46
Operating Income
-1.471.823.612.81.871.99
Interest Expense
-0.21-0.22-0.22-0.24-0.16-0.14
Other Non Operating Income (Expenses)
0.02-0.01-0-0--0
EBT Excluding Unusual Items
-1.661.593.382.561.711.85
Gain (Loss) on Sale of Investments
---1.52---
Gain (Loss) on Sale of Assets
-----0.01-0.05
Asset Writedown
0.310.31----0
Pretax Income
-1.361.91.872.561.71.8
Income Tax Expense
-0.010.010.010.0100
Earnings From Continuing Operations
-1.341.891.862.551.71.8
Minority Interest in Earnings
00.02-0.22-0.280.03-0
Net Income
-1.341.911.642.281.721.79
Net Income to Common
-1.341.911.642.281.721.79
Net Income Growth
-16.21%-28.04%32.36%-4.03%-
Shares Outstanding (Basic)
255255253252240233
Shares Outstanding (Diluted)
255255253252240233
Shares Change
0.01%1.03%0.29%5.02%2.86%-2.25%
EPS (Basic)
-0.010.010.010.010.010.01
EPS (Diluted)
-0.010.010.010.010.010.01
EPS Growth
-15.02%-28.24%26.02%-6.70%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-0.051.86-1.19-0.4-0.850.91
Free Cash Flow Per Share
-0.01-0.01-0.00-0.000.00
Dividend Per Share
0.0020.002-0.0050.0040.004
Dividend Growth
---20.00%2.27%-
Gross Margin
6.94%55.45%64.01%57.31%50.37%59.08%
Operating Margin
-51.05%27.64%44.10%35.25%27.32%34.10%
Profit Margin
-46.59%28.95%20.06%28.66%25.17%30.66%
Free Cash Flow Margin
-1.63%28.28%-14.50%-5.06%-12.47%15.49%
EBITDA
-1.341.953.782.892.052.13
EBITDA Margin
-46.43%29.70%46.29%36.41%29.97%36.43%
D&A For EBITDA
0.130.140.180.090.180.14
EBIT
-1.471.823.612.81.871.99
EBIT Margin
-51.05%27.64%44.10%35.25%27.32%34.10%
Effective Tax Rate
-0.34%0.30%0.24%0.00%0.15%
Revenue as Reported
3.186.898.187.956.835.88